MetaCap

Spero Therapeutics Statistics

NASDAQ: SPROHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.742-0.0843 (-10.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Spero Therapeutics by the numbers

Spero Therapeutics has a market capitalization of $43.2 million based on 58.26M shares outstanding. With trailing EPS of $-0.50, Spero Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.0% below its 50-day average and 60.6% below its 200-day average.

Average daily trading volume is 530.46K shares, or about $393,599 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SPRO valuation vs. peer median

SPRO compared with the median of 8 peer companies
MetricSPROPeer medianDifference
Market cap$43.23M$42.88M+1%
Avg. volume530.46K636.44K-17%

Peer median across 8 companies: RLYB, CRBP, ANVS, INCR, OSTX, GANX, QUCY, BMEA.

Valuation

Market cap
$43.23M
Price / sales (latest FY)
0.65
EPS (TTM)
$-0.50

Price and trading

Previous close
0.8263
Open
0.81
Day range
0.7301 – 0.81
52-week range
0.73 – 3.08
52-week change
-67.88%
Beta
—
Volume
424.81K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
43.23M
Forward Pe
-0.76
Eps
-0.50
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.08
Week52 Low
0.73
Avg Volume
530.46K
Shares Outstanding
58.26M
Ma50
1.11
Ma200
1.88
Earnings Date
Nov 12, 2026
Pct From52w High
-75.91%
Pct From52w Low
1.64%

Related